Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04419870 · ClinicalTrials.gov registry record
Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
A clinical trial of Mitochondrial Disease, sponsored by National Human Genome Research Institute (NHGRI).
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT04419870: Recruiting study of Mitochondrial Disease, sponsored by National Human Genome Research Institute (NHGRI).
NCT04419870 is a study of Mitochondrial Disease that is actively recruiting participants, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 400 participants, above the 108-participant average among 5 other Mitochondrial Disease trials with a reported enrollment target (270% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04419870, a study of Mitochondrial Disease, is actively recruiting participants, sponsored by National Human Genome Research Institute (NHGRI).
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Mitochondrial disease is a rare disorder. It can cause poor growth, developmental delays, muscle weakness, and other symptoms. The disease is usually inherited. It can be present at birth or develop later in life. Infection is a major cause of disease and death in people with this disease. Researchers want to learn more about these infections and the declining health of people who have this disease. To do this, researchers will study the DNA of people who become ill. Their DNA will be compared to the DNA of their household/family members. Objective: To learn more about how genes affect people with mitochondrial disease. Eligibility: People age 2 months and older with mitochondrial disease and their household/family members. .\<TAB\> Design: Participants will complete a questionnaire about their health history. Their medical records may be reviewed. They will give a blood sample. If the participant becomes ill, they may have a videoconference with a doctor or nurse at the NIH to perform a physical exam. They may be contacted after their illness to give updates on their health. They may be asked to give extra blood samples or complete extra questionnaires. Participants genetic data will be put into a database. The data will be labeled with a code and not their name. The data will be shared with other researchers. Participation lasts about 1 year. This may be extended if the participant is very ill.
Primary Outcome
To identify immune signatures that associate with host responses to disease that would allow improved patient stratification and identification of potential therapeutic targets to mitigate the severe symptoms and sequelae of infection in mitochondrial disease.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2020-10-21 |
| Est. Completion | 2026-05-01 |
What NCT04419870 shows while recruiting
NCT04419870 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 108-participant average among 5 other Mitochondrial Disease trials with a reported enrollment target (270% higher).
The record links to 1 condition, with Mitochondrial Disease appearing as the primary indexed condition, and to 0 interventions.
NCT04419870 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT04419870 about?
NCT04419870 is a clinical study titled "Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity". Background: Mitochondrial disease is a rare disorder. It can cause poor growth, developmental delays, muscle weakness, and other symptoms. The disease is usually inherited. It can be present at birth or develop later in life. Infection is a major cause of disease and death in people with this disea...
What is the current status of trial NCT04419870?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2020-10-21. Estimated completion is 2026-05-01.
What conditions does trial NCT04419870 study?
This clinical trial studies the following conditions: Mitochondrial Disease.
Who is sponsoring clinical trial NCT04419870?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04419870 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitochondrial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Validation of Nanosensor Oxygen Measurement
RECRUITING · Phase 1
-
Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels
RECRUITING · Phase 1
-
Mitochondrial Dysfunction in Autism Spectrum Disorder
ACTIVE NOT RECRUITING
-
Assessment of Small Fiber Neuropathy in Rare Diseases Using Sudoscan
COMPLETED · NA
-
Mechanisms of Mitochondrial Defects in Gulf War Syndrome
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI